DRD2 and central nervous system disorder: The fact that sinomenine targets DRD2 (Qiu et al., 2016b), NMDAR (Fang et al., 2017), and GABAA receptors (Yoo et al., 2017) may be of further interest to researchers to explore the profound mechanisms that regulate CNS disorders, especially those associated with changes in neuronal activity.